{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:34:14Z","timestamp":1789961654880,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jaad.2016.12.034","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T07:46:38Z","timestamp":1487922398000},"page":"871-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea"],"prefix":"10.1016","volume":"76","author":[{"given":"Jung Min","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June Hyunkyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Seung","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeol","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Young","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.12.034_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.autrev.2015.12.006","article-title":"Vitiligo: pathogenesis, clinical variants and treatment approaches","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2016.12.034_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","article-title":"Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity?","volume":"81","author":"Xie","year":"2016","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2016.12.034_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1440-0960.2005.00167.x","article-title":"Childhood vitiligo: a prospective hospital-based study","volume":"46","author":"Al-Mutairi","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1684\/ejd.2009.0939","article-title":"Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases","volume":"20","author":"Amerio","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000249466","article-title":"Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo","volume":"171","author":"Betterle","year":"1985","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2016.12.034_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/archderm.144.3.310","article-title":"A Romanian population isolate with high frequency of vitiligo and associated autoimmune diseases","volume":"144","author":"Birlea","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1468-3083.2010.03694.x","article-title":"Vitiligo in children and adolescents: association with thyroid dysfunction","volume":"25","author":"Cho","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.12.034_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2133.1968.tb12282.x","article-title":"Vitiligo, thyroid\u00a0disease and autoimmunity","volume":"80","author":"Cunliffe","year":"1968","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-5945-6-3","article-title":"Anti-thyroid peroxidase antibody and vitiligo: a controlled study","volume":"6","author":"Daneshpazhooh","year":"2006","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/0001555574124128","article-title":"High frequency of thyroid dysfunction in patients with vitiligo","volume":"74","author":"Hegedus","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2016.12.034_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000081479","article-title":"Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo","volume":"210","author":"Iacovelli","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2016.12.034_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jaad.2005.03.032","article-title":"Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo","volume":"53","author":"Kakourou","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2133.2011.10717.x","article-title":"Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo","volume":"166","author":"Kroon","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4158\/EP11205.OR","article-title":"Autoimmune thyroid disease in patients with vitiligo: prevalence study in India","volume":"18","author":"Kumar","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jaad.2016.12.034_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-4362.1996.tb01609.x","article-title":"Organ-specific autoantibodies in vitiligo patients and their relatives","volume":"35","author":"Mandry","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib16","first-page":"885","article-title":"Clinical and immunologic aspects of the relation of acquired leukoderma (vitiligo) to thyroid diseases","volume":"20","author":"Miklaszewska","year":"1972","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.jaad.2016.12.034_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S0365-05962011000200006","article-title":"Vitiligo epidemiological profile and the association with thyroid disease","volume":"86","author":"Nunes","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib18","first-page":"463","article-title":"Thyroid abnormalities in pediatric patients with vitiligo in New York City","volume":"81","author":"Pagovich","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2016.12.034_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000247164","article-title":"Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients","volume":"188","author":"Schallreuter","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2016.12.034_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4161\/derm.1.1.7306","article-title":"Vitiligo vulgaris and autoimmune diseases in Japan: a report\u00a0from vitiligo clinic in Kyoto University Hospital","volume":"1","author":"Tanioka","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.jaad.2016.12.034_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-4632.2010.04665.x","article-title":"Relevance of autoimmune thyroiditis in children and adolescents with vitiligo","volume":"50","author":"Uncu","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1365-2230.2009.03671.x","article-title":"An approach to the correlation between vitiligo and autoimmune thyroiditis in Chinese children","volume":"35","author":"Yang","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2249.2003.02089.x","article-title":"Autoimmune diseases in vitiligo: do anti-nuclear antibodies decrease thyroid volume?","volume":"131","author":"Zettinig","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2016.12.034_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/heapol\/czn037","article-title":"Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage","volume":"24","author":"Kwon","year":"2009","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.jaad.2016.12.034_bib25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-2133.2012.11198.x","article-title":"The prevalence of thyroid disease in patients with vitiligo: a systematic review","volume":"167","author":"Vrijman","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0019-5154.39733","article-title":"Thyroid dysfunction and thyroid antibodies in Iranian patients with vitiligo","volume":"53","author":"Sedighe","year":"2008","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000357807","article-title":"Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study","volume":"228","author":"Ingordo","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2016.12.034_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaad.2015.08.063","article-title":"Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study","volume":"74","author":"Gill","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/120347541201600408","article-title":"Vitiligo and associated autoimmune disease: retrospective review of 300 patients","volume":"16","author":"Sawicki","year":"2012","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.jaad.2016.12.034_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12166","article-title":"Autoimmune thyroid disease\u00a0in vitiligo: multivariate analysis indicates intricate pathomechanisms","volume":"168","author":"Gey","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2016.12.034_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/BF03348863","article-title":"Thyroid autoimmunity and female gender","volume":"16","author":"Chiovato","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jaad.2016.12.034_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2009.10.003","article-title":"Thyroid cancer and inflammation","volume":"321","author":"Guarino","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jaad.2016.12.034_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000371741","article-title":"Iodine, thyroid autoimmunity and cancer","volume":"4","author":"Fiore","year":"2015","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.jaad.2016.12.034_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3803\/EnM.2013.28.4.275","article-title":"The diagnosis and management of hyperthyroidism in Korea: consensus report of the korean\u00a0thyroid association","volume":"28","author":"Moon","year":"2013","journal-title":"Endocrinol Metab (Seoul)"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216312956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:44:00Z","timestamp":1759272240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216312956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0190962216312956"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}